Opdivo (nivolumab) is an immunotherapy treatment used to treat cancers such as melanoma, lung, colorectal, malignant pleural mesothelioma, urinary tract, gastric, liver, Hodgkin lymphoma, and head and neck cancers. It is administered as an intravenous infusion every 2 to 4 weeks, depending on your cancer type. opdivo price